Mergers and acquisitions in healthcare are rarely simple.
Financial models are scrutinized. Brand alignment is debated. Leadership structures are redesigned. Contracts are reviewed contract to contract, line by line.
But one operational area often underestimated during integration is value analysis infrastructure and how it flows.
And that oversight can quietly undermine the very efficiencies the merger was intended to create.
Because when two health systems merge, they don’t just combine assets.
They combine processes.
Two Systems. Two Sets of Rules.
On paper, both organizations may have strong healthcare value analysis programs. Each may have:
- Established committees
- Defined approval timelines
- Product request forms
- Vendor engagement policies
- Trial processes
- Financial modeling practices
Independently, both systems may function well.
But once merged, friction emerges almost immediately.
Consider the realities:
- System A uses a centralized committee model; System B is decentralized by service line.
- System A requires 60-day review cycles; System B pushes approvals through in 30 days.
- System A mandates strict financial modeling before trials; System B emphasizes clinician sponsorship first.
- System A documents everything in a shared drive; System B relies on email and spreadsheets.
Suddenly, what once felt organized now feels fragmented.
Without alignment, healthcare value analysis becomes inconsistent across the newly formed enterprise.
And inconsistency is expensive.
The Hidden Cost of Process Misalignment
In a merger, leadership often focuses on contract standardization and purchasing leverage. But contracts cannot be unified if product decisions are not unified.
When approval processes differ across facilities:
- Clinicians continue using different products.
- Trials are duplicated unnecessarily.
- Vendor commitments conflict.
- Standardization stalls.
- Savings projections remain theoretical.
Most critically, governance fractures.
If one hospital approves a product through one pathway and another hospital approves it through a different one, the organization no longer has a unified healthcare value analysis structure.
It has parallel systems operating under one corporate umbrella.
That is not integration. That is coexistence.
Governance Is Not a Policy – It Is a Process
In my experience, organizations often attempt to solve merger misalignment by rewriting policy manuals.
Policies matter, no doubt.
But policies without workflow control are suggestions, not governance.
True governance in healthcare value analysis requires visibility into:
- Who submitted the request
- Which stakeholders were engaged
- What financial assumptions were modeled
- What clinical evidence was reviewed
- What implementation steps were assigned
- Whether the conversion was verified
When two systems merge without centralized workflow infrastructure, those answers exist in different formats, different folders, and different institutional memories.
And that fragmentation directly impacts compliance and contract integrity.
Contract Compliance Depends on Decision Alignment
A merged health system often renegotiates contracts to leverage greater purchasing volume. But contract compliance depends on behavioral alignment.
If facilities continue to approve and implement products through different pathways:
- On-contract compliance erodes.
- Product standardization stalls.
- Savings leakage increases.
- Vendor leverage weakens.
Strong healthcare value analysis must serve as the enforcement engine behind contract strategy.
Without centralized workflow, there is no reliable mechanism to ensure that newly negotiated contracts translate into operational adoption.
You cannot standardize what you cannot see.
Centralized Workflow as the Backbone of Unified Governance
The turning point in successful integrations occurs when organizations stop trying to harmonize processes conceptually — and instead centralize them structurally.
A unified workflow platform becomes the backbone of enterprise-wide healthcare value analysis.
Here’s why.
- A Single Point of Entry Eliminates Parallel Pathways
In a merged system, every product request, regardless of location, should enter through the same intake structure.
That does not mean every request follows the same timeline. It means every request follows the same framework.
Centralized intake ensures:
- Consistent documentation
- Standardized financial inputs
- Defined stakeholder engagement
- Visibility across the enterprise
Now, instead of two organizations making separate decisions, the merged entity operates under one governed process.
That is foundational to scalable healthcare value analysis.
- Enterprise-Wide Visibility Replaces Institutional Silos
When workflows are centralized, leadership gains enterprise visibility.
They can see:
- What products are being evaluated across facilities
- Where trials are occurring
- Which committees are reviewing similar items
- How long approvals are taking
- Where bottlenecks exist
This visibility prevents duplication and accelerates alignment.
It also reinforces accountability.
In strong healthcare value analysis, decisions are not hidden within local committees. They are transparent across the system.
Transparency drives trust, especially during integration.
- Implementation Becomes Coordinated, Not Fragmented
Approval is only the beginning.
In a merger environment, implementation complexity multiplies:
- Multiple item masters
- Multiple ERP systems
- Different clinician education models
- Varied conversion timelines
Without centralized workflow tracking, implementation drifts.
A unified platform ensures:
- Assigned tasks
- Clear deadlines
- SKU conversion tracking
- Financial impact monitoring
- Confirmation of adoption
High-performing healthcare value analysis extends beyond committee approval into disciplined execution.
In a merger, that discipline determines whether projected savings materialize.
Cultural Alignment Through Process Alignment
One of the most overlooked benefits of centralized workflow during a merger is cultural stabilization.
Mergers generate uncertainty.
Clinicians question whether their input will be diminished. Supply chain teams worry about losing autonomy. Leaders worry about losing momentum.
Centralized, transparent healthcare value analysis processes provide reassurance.
When everyone can see:
- How decisions are made
- Who participates
- What criteria are applied
- How long reviews take
The organization shifts from “us versus them” to “one structured system.”
Process clarity reduces political tension.
And in mergers, clarity is currency.
The Strategic Question Every Merged System Must Ask
It is easy to assume that two mature value analysis programs will integrate naturally.
They will not.
Without centralized workflow control, the merged organization risks:
- Decision variability
- Contract noncompliance
- Duplicated effort
- Savings leakage
- Governance exposure
The strategic question becomes:
“Do we have a single, unified operating infrastructure for healthcare value analysis?”
If the answer is no, the merger remains operationally divided, regardless of financial consolidation.
Healthcare Value Analysis as Enterprise Infrastructure
Healthcare mergers are not slowing.
As systems expand regionally and nationally, the complexity of product governance increases exponentially.
In this environment, healthcare value analysis must evolve from a committee-based function to an enterprise infrastructure function.
It must:
- Govern decisions consistently
- Protect contract integrity
- Align stakeholders across facilities
- Ensure disciplined implementation
- Preserve institutional memory
Centralized workflow is not simply a software choice.
It is a governance decision.
And in a merged health system, governance determines whether integration succeeds or fractures under its own complexity.
When two systems become one, process must become one as well.
That is the backbone of unified healthcare value analysis and the difference between theoretical synergy and operational reality.
Discover the power of VAMS®—click the Request a Demo button below to get started.
